Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23892)

• Formulation Name: Selumetinib 25 mg capsule
• Company: Astrazeneca Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Selumetinib	(DMC7W6R)	Melanoma	2C30	Phase 3

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carrageenan	(E00714)	Not Available	Emulsion stabilizing agent; Gelling agent; Microencapsulating agent; Modified-release agent; Suspending agent; Viscosity-controlling agent
FD&C blue no. 2	(E00446)	2723854	Colorant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Glyceryl monooleate	(E00473)	5283468	Bioadhesive material; Emollient; Emulsifying agent; Emulsion stabilizing agent; Gelling agent; Modified-release agent; Surfactant
Haematite red	(E00236)	14833	Colorant
Hypromellose	(E00634)	Not Available	Coating agent
Potassium chloride	(E00074)	4873	Tonicity agent
Pregelatinized starch	(E00674)	Not Available	Binding agent; Diluent; Disintegrant
Shellac	(E00695)	Not Available	Coating agent; Film/membrane-forming agent; Microencapsulating agent; Modified-release agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Tocophersolan	(E00679)	Not Available	Antioxidant; Binding agent; Emulsifying agent; Ointment base; Solubilizing agent; Surfactant; Suspending agent
Water	(E00035)	962	Solvent